StacheStrong

1.2K posts

StacheStrong banner
StacheStrong

StacheStrong

@StacheStrong

$4M+ Raised • Brain Cancer Research • 40+ Grants Funded • Patient Advocacy for ALL • Golf Tournament • 5K • 350+ #BrewStacheStrong breweries 🍻 • We #Believe

Katılım Kasım 2018
159 Takip Edilen517 Takipçiler
Sabitlenmiş Tweet
StacheStrong
StacheStrong@StacheStrong·
Thank you @MeghanMcCain and the entire team @TheView for bringing our family’s story to light as we fight to raise funds and awareness for brain cancer. We miss GJ every day and have continued his fight against GBM. We’ve raised over $1M for brain cancer research - join us today!
The View@TheView

“I just wish he was still next to me.” After losing his brother GJ to glioblastoma, Colin Gerner talks with @MeghanMcCain — who lost her father to the same brain cancer — about how he’s honoring his legacy by starting @StacheStrong to support brain cancer research and awareness.

English
0
1
4
0
StacheStrong
StacheStrong@StacheStrong·
@maorshlomo For our nonprofit a look and the $7M we’ve funded following my 30-year old brother’s passing to Glioblastoma. Learn more at StacheStrong.org. Thanks for your efforts and support!!!
English
0
0
0
20
StacheStrong retweetledi
Maor Shlomo
Maor Shlomo@MaorShlomo·
I'm looking to invest in cancer research and breakthrough treatment companies Cancer is humanity's worst enemy, and unfortunately, it's one of the few frontier problems i don't see getting solved in the next 2-3 years.  I'll be able to write checks up to a few million (usually up to a million).  I will work extremely hard to help the founders. I'll leverage my network as much as possible to overcome bureaucracies and help hunt down talent for every company I'm investing in. Things I'm particularly interested in:  1. Accelerating clinical trials: As AI gets smarter and allows novel hypotheses on new drug targets, clinical trials and bureaucracy will remain the biggest bottleneck to fight cacner. 2. Repurposed drugs: the current cost of Phase 3 clinical trials only allows patentable solutions to be economically viable. It resonates that are probably many other treatments and potentially impactful drugs that won't be included in the Standard of Care as they haven't gone through phase 3 clinical trials.  3. Personalized medicine: organoids, digital twin, faster cycle from biopsy -> identifying targets -> creating customised solutions, such as mRNA vaccines, custom Antibody-Drug Conjugates (ADCs), and novel ways of triggering one's immune system.  4. Improving measurement: Currently, the standard PET-CT method does not allow weekly measurement of disease progression. Identifying a superior method to allow weekly measurement of progression could be instrumental in cutting down the time it takes to find a drug the body respond to. Anyone who can connect me to relevant companies will be widely appreciated
English
144
121
1.4K
103.6K
StacheStrong retweetledi
StacheStrong retweetledi
StacheStrong retweetledi
The New York Times
The New York Times@nytimes·
Breaking News: Madeleine Wickham, who wrote the “Confessions of a Shopaholic” novel series under the pen name Sophie Kinsella, becoming an international sensation, died at 55. Read more: nyti.ms/3XMvTPX
The New York Times tweet media
English
68
356
1.5K
261.7K
StacheStrong retweetledi
Sophie Kinsella
Sophie Kinsella@KinsellaSophie·
We are heartbroken to announce the passing this morning of our beloved Sophie (aka Maddy, aka Mummy). She died peacefully, with her final days filled with her true loves: family and music and warmth and Christmas and joy. We can't imagine what life will be like without her. 1.
Sophie Kinsella tweet media
English
905
1.3K
15.8K
783.8K
StacheStrong retweetledi
SBTF
SBTF@sbtfoundation·
Congratulations to Brain Tumor Funders’ Collaborative (BTFC) Grant Recipient Paul Northcott, PhD of St. Jude Children’s Research Hospital for his innovative project: Maximizing Detection of Childhood Brain Tumors in Biofluids.
SBTF tweet media
English
1
1
1
71
StacheStrong retweetledi
American Brain Tumor Association
The American Brain Tumor Association is proud to stand alongside the Brain Tumor Funders’ Collaborative (BTFC) in announcing two new grants totaling $1 million to advance liquid biopsy research for brain tumors. Congratulations to Paul Northcott, PhD (St. Jude Children’s Research Hospital) and Ching Lau, MD, PhD (Connecticut Children’s) for their outstanding proposals! These grants represent a powerful investment in innovation and collaboration, fueling discoveries that bring hope to patients, families, and caregivers everywhere. Together with our BTFC partners, we’re driving forward groundbreaking research that moves us closer to new answers and better outcomes for the brain tumor community. 💙 @BrainTumourFdn @NBTStweets @PBTF @jude_children @beadragonmaster @glioblastomaorg @sontagfdn @sbtfoundation @StacheStrong
American Brain Tumor Association tweet media
English
0
3
6
351
StacheStrong retweetledi
Dolphins Cancer Challenge
Dolphins Cancer Challenge@TackleCancer·
Each year, ~15,000 Americans are diagnosed with glioblastoma. The 5-year survival rate? Just 7%.   That’s why the DCC x @StacheStrong partnership is so vital. In year one, we helped fund groundbreaking research at @SylvesterCancer, supporting the work of Dr. Ashish Shah and Dr. Rumela Chakrabarti. We’re proud to stand with the Gerner family and all those fighting GBM. #NationalGioblastomaDay
Dolphins Cancer Challenge tweet mediaDolphins Cancer Challenge tweet media
English
0
2
7
1.2K
StacheStrong retweetledi
LiveNOWLab
LiveNOWLab@LiveNOWLab·
🚨NATIONAL-RECRUITMENT🚨 Virtual psychotherapy targeting fears of tumor recurrence. Specifically designed for brain tumor community. Seeking patient & caregivers. Participate individually or in dyad. #repost @BTSMchat Funded by @theNCI @NBTStweets @StacheStrong
LiveNOWLab tweet media
English
0
3
5
736
StacheStrong retweetledi
Michael Ivan, MD, MBS, FAANS
Michael Ivan, MD, MBS, FAANS@michaelivanmd·
On Glioblastoma Awareness Day, I’m proud to share that my research lab has been awarded the 2025 Women’s Cancer Association Research Grant for our work targeting #glioblastoma invasion. Glioblastoma is the most common and aggressive brain cancer, affecting over 250,000 people worldwide each year. Its most devastating feature is invasion—the way tumor cells spread into healthy brain tissue, causing severe cognitive and neurological damage. That’s exactly why our lab has chosen to focus our research on stopping invasion. Today, we honor the patients, families, researchers, physicians, and supporters who face this disease head-on. 💙 Please join us in raising awareness and fighting back against brain cancer. #GlioblastomaAwareness #BrainCancerResearch #StopInvasion #WCAResearchGrant #NeuroOncology #ScienceForHope @sylvestercancer @glioblastomaresearch @stachestrong #glioblastomaawarenessday
Michael Ivan, MD, MBS, FAANS tweet media
English
6
5
73
3.2K
StacheStrong
StacheStrong@StacheStrong·
So much more needs to be done to fight this disease @MittRomney - for all those like Mia and my brother. Give us a look at StacheStrong.org and we ask you to join us in funding brain cancer research.
Mitt Romney@MittRomney

Heavy heart with the passing of my friend and colleague, Mia Love. Her energy, enthusiasm and wit made her a stand-out member of Congress. Her faith and fortitude made her a model for me and for countless others. We will dearly miss you, Mia.

English
0
1
2
678
StacheStrong retweetledi
Mia Love
Mia Love@MiaBLove·
Love Family: With grateful hearts filled to overflowing for the profound influence of Mia on our lives, we want you to know that she passed away peacefully today. She was in her home surrounded by family. In the midst of a celebration of her life and an avalanche of happy memories, Mia quietly slipped the bands of mortality and, as her words and vision always did, soared heavenward. We are thankful for the many good wishes, prayers and condolences. We are taking some time as a family and will provide information about funeral services and a public celebration of her life in the days to come.
Mia Love tweet media
English
5.1K
4.3K
38K
5.7M
StacheStrong retweetledi
Professor Richard Scolyer AO
Professor Richard Scolyer AO@ProfRAScolyer·
Unfortunately there is a larger volume of quickly growing brain cancer (glioblastoma, IDH WT, unmethylated etc) in my left brain. The prognosis is poor. Whilst some of my recurrent tumour was removed last week, some of it couldn’t be because of its site. While the neoadjuvant triple doses of immunotherapy &/or anticancer vaccination I received may have made a difference in my brain tumour & survival, more work needs to be done in a clinical trial to prove this. Either way, I am proud of the data produced after treatment with neoadjuvant immunotherapy (and recently published in the prestigious journal Nature Medicine) which I hope will make a difference for others. I greatly appreciate the support of all my family, friends & colleagues who have been looking after me so well & the incredible research that has been performed. I hope the latter will change the field & patient outcomes in the not too distant future. @SydneyLHD @Sydney_Uni @NthSydHealth @COBLH @AllenAndUnwin @gmaddox @Channel9 @AllisonLangdon @smh @Dr_Brindha #glioblastoma
Professor Richard Scolyer AO tweet mediaProfessor Richard Scolyer AO tweet mediaProfessor Richard Scolyer AO tweet mediaProfessor Richard Scolyer AO tweet media
English
790
469
6.3K
482K